Vaccination benefits, risks and safety: The need for a complete picture

Bulletin of the World Health Organization

Volumn 78, Issue 2, 2000, Pages 219-221

  Pless, Robert ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; IMMUNOPROPHYLAXIS; NOTE; RISK BENEFIT ANALYSIS;

BIOLOGY; CRITIQUE; DELIVERY OF HEALTH CARE; HEALTH; HEALTH SERVICES; IMMUNIZATION; PRIMARY HEALTH CARE; PUBLIC HEALTH; RISK FACTORS; SAFETY; VACCINATION; VACCINES; WORLD;

HUMANS; RISK ASSESSMENT; VACCINES; WORLD HEALTH;

EID: 0034016287     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Gellin B. National Network for Immunization Information 1999 (unpublished information). For more information about this initiative, refer to: http://www.idsociety.org/vaccine
2. Gangarosa EJ et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet, 1998, 351: 356-361.
3. Wilson G. The hazards of immunization. London, Athlone Press, 1967.
4. Hutin YJF, Chen RT. Injection safety: a global challenge. Bulletin of the World Health Organization, 1999, 77: 787-788.
5. Ward BJ. Vaccine adverse events in the new millennium: is there reason for concern? Bulletin of the World Health Organization, 2000, 78: 205-215.
6. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet, 1998, 351: 611-612.
7. Communicable Disease Surveillance Centre. MMR vaccine falls after adverse publicity. Communicable Disease Report Weekly, 1998, 8: 41.
8. Karvonen M, Cepaitis Z, Tuomilehto J. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. British Medical Journal, 1999, 318: 1169-1172.
9. McNamee D. Communicating drug-safety information. Lancet, 1997, 350: 1646.